NM Magazine logo

Tag: Winter 2022

  • Northwestern Selected as Home for Journal of Clinical Investigation

    Northwestern Selected as Home for Journal of Clinical Investigation

    Northwestern University Feinberg School of Medicine has been selected to serve as the home of the Journal of Clinical Investigation for its next five-year term, and Elizabeth McNally, MD, PhD, has been elected as the journal’s next editor-in-chief.

  • Northwestern Scientists Explore Impacts of Genomic Variation in Disease

    Northwestern Scientists Explore Impacts of Genomic Variation in Disease

    Northwestern is part of the Impact of Genomic Variation on Function (IGVF) Consortium, a $185 million NIH project that will explore the millions of genetic variants that cause disease around the world.

  • Tiny Dancers

    Tiny Dancers

    Samuel Stupp, PhD, has discovered how to control the collective motion of more than 100,000 “dancing” molecules within a nanofiber — a strategy that has the potential to reverse spinal cord injuries and more.

  • Global Vision

    Global Vision

    Robert Murphy, MD, leads research and education initiatives around the world while combating COVID-19 misinformation closer to home.

  • Outsmarting a Trickster

    Outsmarting a Trickster

    Feinberg scientists discovered that herpesviruses perform a sneaky maneuver to hide within the nervous system for life.

  • Healthy Mother, Healthy Child

    Healthy Mother, Healthy Child

    Northwestern Medicine goes the extra mile to support people with high-risk pregnancies.

  • A Banner Year

    A Banner Year

    Feinberg had an extraordinary 2021. Scientists’ work was published in a range of high-impact journals, presenting a broad spectrum of critical discoveries.

  • Genome Editing Made Possible on Cells Lining Blood Vessel Walls

    Genome Editing Made Possible on Cells Lining Blood Vessel Walls

    The laboratory of YouYang Zhao, PhD, developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to vascular endothelial cells.

  • Drug May Benefit Patients with Heart Failure

    Drug May Benefit Patients with Heart Failure

    Dapagliflozin, commonly used to treat type 2 diabetes, improved heart failure-related symptoms and physical limitations in patients with heart failure with preserved ejection fraction.

  • In Memoriam

    In Memoriam

    s and friends of the following alumni (listed in order of their graduation year) and faculty who have passed away. All dates are in 2021.